Minimal residual disease (MRD) and biomarker in CLL

Barbara Eichorst | Onkologi /hematologi | desember 21, 2017

 

Speaker: Barbara Eichorst

What are the clinical role of MRD negativity and biomarkers in CLL. Click and hear the opinion from Dr. Barbara Eichorst, haematologist at the University Clinic in Cologne. Why is it important for the clinical practice?

3bx3

3bx3

3bx3